Drug:
Reaction: ANAEMIA
20250101 - 20251231
No. 301 - 400
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
301 | 25086982 |
RO |
51 | 1 |
Secondary immunodeficiency, Pneumonia bacterial, Influenza, Acute respiratory failure, Thrombocytopenia, Leukopenia, Neutropenia, Thrombophlebitis, Anaemia, |
||||
CARFILZOMIB, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
302 | 25087086 |
AR |
2 | |
Brain neoplasm, Anaemia, Red blood cell count decreased, Gastrointestinal disorder, Uterine neoplasm, Inappropriate schedule of product administration, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
303 | 25087341 |
FR |
75 | 2 |
Leukaemia, Anaemia, |
||||
304 | 25087646 |
JP |
82 | 1 |
Portal hypertension, Oesophageal varices haemorrhage, Portal vein thrombosis, Anaemia, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
305 | 25087975 |
FR |
77 | 1 |
Sepsis, Confusional state, Neutrophil count decreased, Bone pain, Epistaxis, Urinary retention, Skin lesion, Febrile neutropenia, Platelet count decreased, Anaemia, Asthenia, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, ISATUXIMAB, CEFTRIAXONE, CEFTRIAXONE SODIUM, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, APIXABAN, PANTOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ZOLEDRONIC ACID, CEFTAZIDIME, CEFTAZIDIME, FENTANYL, MORPHINE, |
||||
306 | 25088550 |
FR |
53 | 2 |
Hypercalcaemia, Pneumocystis jirovecii pneumonia, Blood 1,25-dihydroxycholecalciferol increased, Acute kidney injury, Anaemia, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
307 | 25088659 |
PL |
77 | 2 |
Pancytopenia, Anaemia, Thrombocytopenia, Neutropenia, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
308 | 25088677 |
BA |
64 | 2 |
Bone marrow failure, Neutropenia, Inflammatory marker increased, Anaemia, Thrombocytopenia, Haemorrhage subcutaneous, |
||||
CISPLATIN, ETOPOSIDE, CYTARABINE, METHYLPREDNISOLONE, RITUXIMAB, |
||||
309 | 25089002 |
SE |
64 | 2 |
Spinal fracture, Depressed level of consciousness, Pain, Musculoskeletal disorder, Muscle spasms, Discoloured vomit, C-reactive protein increased, Full blood count increased, Dizziness, Pyrexia, Headache, Toxicity to various agents, Fatigue, Urinary incontinence, Gait disturbance, General physical health deterioration, Alopecia, Depression, Osteoporosis, Anaemia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
310 | 25089007 |
US |
33 | 2 |
Abdominal pain, Palpitations, Pneumonia bacterial, Enterobacter bacteraemia, Sepsis, Influenza, Tachycardia, Hodgkin^s disease nodular sclerosis refractory, Chronic graft versus host disease, Graft versus host disease in liver, Immunodeficiency, Renal atrophy, Pneumonitis, Major depression, Immunosuppression, Herpes simplex viraemia, Thrombocytopenia, Pyrexia, Muscle disorder, Generalised anxiety disorder, Malnutrition, Rash, Respiratory tract infection viral, Viral upper respiratory tract infection, Cough, Anaemia, |
||||
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, BLEOMYCIN SULFATE, DACARBAZINE, RUXOLITINIB, RUXOLITINIB, VINBLASTINE SULFATE, ACYCLOVIR, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LORAZEPAM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, BECLOMETHASONE DIPROPIONATE, BENZONATATE, CETYLPYRIDINIUM CHLORIDE, BUDESONIDE, ISAVUCONAZONIUM SULFATE, DEXTROMETHORPHAN HYDROBROMIDE, AND GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN, ERGOCALCIFEROL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, ISAVUCONAZONIUM SULFATE, POTASSIUM CHLORIDE, DRONABINOL, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, LETERMOVIR, TACROLIMUS, ELTROMBOPAG OLAMINE, PANTOPRAZOLE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, MIRTAZAPINE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE, OLANZAPINE, OLANZAPINE PAMOATE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, |
||||
311 | 25089229 |
|||
Bone marrow disorder, Anaemia, |
||||
RUXOLITINIB, RUXOLITINIB, ALLOPURINOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROXYUREA, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, LISINOPRIL, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
312 | 25089560 |
US |
63 | 1 |
Muscle spasms, Anaemia, Pain, |
||||
RIOCIGUAT, RIOCIGUAT, RIOCIGUAT, |
||||
313 | 25089739 |
US |
||
Anaemia, Gastrointestinal injury, Crystal deposit intestine, |
||||
314 | 25090032 |
GB |
2 | |
Leukopenia, Anaemia, Neutrophil count decreased, Platelet count decreased, Eosinophil count decreased, Off label use, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, LORAZEPAM, PROMETHAZINE, |
||||
315 | 25090251 |
US |
53 | |
Insomnia, Constipation, Urinary retention, Toxicity to various agents, Muscle twitching, Weight increased, Oedema, Therapy cessation, Decreased appetite, Myalgia, Muscle spasms, Foot fracture, Fall, Foot fracture, Renal pain, Renal cyst, Hypertension, Tachycardia, Dizziness, Anaemia, Therapy interrupted, Withdrawal syndrome, Head injury, Faecaloma, Bone density decreased, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
316 | 25090403 |
US |
71 | 2 |
Drug intolerance, Plantar fasciitis, Anaemia, Metastatic malignant melanoma, |
||||
LENALIDOMIDE, |
||||
317 | 25090765 |
CN |
69 | 2 |
Neutropenic sepsis, Respiratory failure, Platelet count decreased, Anaemia, Pneumonia, |
||||
BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, SELINEXOR, SELINEXOR, SELINEXOR, TISLELIZUMAB-JSGR, TISLELIZUMAB-JSGR, TISLELIZUMAB-JSGR, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, |
||||
318 | 25090813 |
US |
2 | |
Anaemia, Haemorrhage, |
||||
RIVAROXABAN, |
||||
319 | 25090890 |
|||
Ill-defined disorder, Anaemia, |
||||
RUXOLITINIB, RUXOLITINIB, |
||||
320 | 25091051 |
FR |
74 | 1 |
Gastric ulcer, Gastrointestinal haemorrhage, Anaemia, |
||||
PREDNISONE, |
||||
321 | 25091838 |
JP |
67 | 2 |
Myelodysplastic syndrome, Anaemia, |
||||
NILOTINIB, |
||||
322 | 25092021 |
CN |
55 | 1 |
Myelosuppression, Platelet count decreased, Mouth ulceration, Neutrophil count decreased, Anaemia, White blood cell count decreased, |
||||
VENETOCLAX, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, CYTARABINE, |
||||
323 | 25081765 |
CA |
49 | 2 |
Abdominal discomfort, Abdominal distension, Anaemia, C-reactive protein increased, Crohn^s disease, Decreased appetite, Diarrhoea, Haematochezia, Intestinal polyp, Mouth ulceration, Oedema peripheral, Off label use, Oropharyngeal plaque, Tongue abscess, Tongue coated, Vomiting, Weight decreased, Off label use, |
||||
METHYLPHENIDATE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, |
||||
324 | 25082100 |
EG |
79 | 1 |
Ulna fracture, Plasma cell myeloma, Spinal fracture, Anaemia, Fall, |
||||
BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, DENOSUMAB, ERYTHROPOIETIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
325 | 25082333 |
PL |
61 | 1 |
Product use in unapproved indication, Chronic kidney disease, Drug dependence, Anaemia, Metastases to lung, Confusional state, Hyperaesthesia, Toxicity to various agents, Decreased appetite, Constipation, Prostatic specific antigen increased, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, FENTANYL, ABIRATERONE ACETATE, ABIRATERONE, BICALUTAMIDE, DENOSUMAB, DICLOFENAC, DICLOFENAC SODIUM, DOCETAXEL, DOCETAXEL ANHYDROUS, FENTANYL, GABAPENTIN, IRON, KETOPROFEN, MORPHINE, PREGABALIN, ERGOCALCIFEROL, |
||||
326 | 25082562 |
PE |
46 | 2 |
Vomiting, Weight decreased, Anaemia, Discomfort, |
||||
LIRAGLUTIDE, LIRAGLUTIDE, |
||||
327 | 25082693 |
US |
||
Pneumonia, Neutropenia, Thrombocytopenia, Dehydration, Infection, Bronchitis, Infusion related reaction, Diarrhoea, Constipation, Nausea, Upper respiratory tract infection, Oedema peripheral, Fatigue, Asthenia, Pyrexia, Back pain, Muscle spasms, Dyspnoea, Cough, Peripheral sensory neuropathy, Decreased appetite, Anaemia, |
||||
DARATUMUMAB, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
328 | 25083573 |
US |
||
Hot flush, Anaemia, Constipation, |
||||
RELUGOLIX, RELUGOLIX, IRON, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, DAROLUTAMIDE, VITAMIN C, CALCIUM CARBONATE, ANTACID, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ERGOCALCIFEROL, FUROSEMIDE, HYDROXYZINE, ISOSORBIDE MONONITRATE, LANSOPRAZOLE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PIOGLITAZONE, ACETAMINOPHEN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
329 | 25083864 |
FR |
||
Gastrointestinal haemorrhage, Anaemia, |
||||
RIVAROXABAN, |
||||
330 | 25084107 |
ES |
67 | 2 |
Pneumonia, Anaemia, Thrombocytopenia, Hypertension, |
||||
CARBOPLATIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, BEVACIZUMAB, |
||||
331 | 25084216 |
GB |
1 | |
Thrombocytopenia, Anaemia, |
||||
CLOZAPINE, |
||||
332 | 25084343 |
CN |
||
Temperature intolerance, Pyrexia, Anaemia, Platelet count decreased, Myelosuppression, |
||||
333 | 25084348 |
US |
63 | 2 |
Acute kidney injury, Drug reaction with eosinophilia and systemic symptoms, Anaemia, Human herpesvirus 6 infection reactivation, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ACYCLOVIR, |
||||
334 | 25084505 |
SE |
64 | 1 |
Duodenal ulcer, Melaena, Anaemia, |
||||
APIXABAN, |
||||
335 | 25084528 |
JP |
73 | |
Anaemia, Pancytopenia, Haemolytic anaemia, Blood creatine phosphokinase increased, Myasthenia gravis, Eyelid ptosis, Dysphagia, |
||||
TREMELIMUMAB, DURVALUMAB, |
||||
336 | 25084534 |
US |
68 | 2 |
Hip arthroplasty, Fatigue, Anaemia, Pain, Arthralgia, |
||||
PALBOCICLIB, PALBOCICLIB, APIXABAN, |
||||
337 | 25084548 |
US |
1 | |
Anaemia, Influenza, Asthenia, Drug interaction, |
||||
TAFAMIDIS, TAFAMIDIS, APIXABAN, APIXABAN, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, SPIRONOLACTONE, ROSUVASTATIN, EZETIMIBE, FUROSEMIDE, FERROUS SULFATE, EMPAGLIFLOZIN, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, |
||||
338 | 25084761 |
US |
79 | 2 |
Drug ineffective, Oedema peripheral, Anaemia, Product use in unapproved indication, |
||||
SIROLIMUS, APREMILAST, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, HUMAN IMMUNOGLOBULIN G, RITUXIMAB, |
||||
339 | 25085430 |
CH |
81 | 1 |
Leukopenia, Anaemia, Encephalitis, Bacteraemia, Thrombocytopenia, Neutropenia, Drug ineffective, Pancytopenia, Listeriosis, Lymphopenia, |
||||
CARBOPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
340 | 25085507 |
IT |
||
Anaemia, Melaena, |
||||
RIVAROXABAN, |
||||
341 | 25085587 |
CA |
71 | 2 |
Chronic sinusitis, Anaemia, Colitis, Colitis ulcerative, Abdominal pain, Constipation, Dyspepsia, Erythema, Female genital tract fistula, Frequent bowel movements, Haematochezia, Headache, Macular degeneration, Malaise, Nausea, Oral candidiasis, Pain, Paraesthesia oral, Procedural pain, Proctitis, Pyrexia, Radiculopathy, Rectal haemorrhage, Vaginal discharge, Vaginal flatulence, Weight decreased, Infusion related reaction, Off label use, Drug ineffective, Therapeutic product effect incomplete, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, AMOXICILLIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN DIHYDRATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETIC ACID, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALPRAZOLAM, ALPRAZOLAM, ALPRAZOLAM, HYDROCHLOROTHIAZIDE, HYDROMORPHONE HYDROCHLORIDE, PREGABALIN, ATROPINE SULFATE, ATROPINE SULFATE MONOHYDRATE, ATROPINE SULFATE INJECTION, FLUTICASONE FUROATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CLARITHROMYCIN, CALCIUM, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, CITRIC ACID, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, HYDROCORTISONE, CUPRIC OXIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DESONIDE, DEXPANTHENOL, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, DIMETHYL SULFOXIDE, ERGOCALCIFEROL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, VEDOLIZUMAB, ERTAPENEM, ERTAPENEM SODIUM, ERTAPENEM, ERTAPENEM SODIUM, ERTAPENEM, ERTAPENEM SODIUM, FENTANYL CITRATE, FENTANYL CITRATE, FLUCONAZOLE, FLUCONAZOLE, METRONIDAZOLE, FLUTICASONE PROPIONATE, FLUTICASONE FUROATE, FLUTICASONE PROPIONATE, NITROGLYCERIN, GLYCERIN, GLYCERIN SUPPOSITORY, GLYCERIN, GLYCERIN SUPPOSITORY, GLYCERIN, GLYCERIN SUPPOSITORY, GLYCERIN, GLYCERIN SUPPOSITORY, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, NICOTINE TRANSDERMAL SYSTEM PATCH, ADALIMUMAB, ADALIMUMAB, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCORTISONE BUTYRATE, INFLIXIMAB, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ISONIAZID, ISONIAZID, KENALOG, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, METHOTREXATE, METHOTREXATE SODIUM, MIDAZOLAM HYDROCHLORIDE, MORPHINE SULFATE, MAGNESIUM CARBONATE, MAGNESIUM OXIDE, MESALAMINE, MESALAMINE, MESALAMINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METOCLOPRAMIDE HYDROCHLORIDE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MORPHINE, MORPHINE, POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE, MORPHINE SULFATE, MUPIROCIN, MUPIROCIN CALCIUM, MUPIROCIN, MUPIROCIN CALCIUM, MUPIROCIN, MUPIROCIN CALCIUM, MUPIROCIN CALCIUM, NITROGLYCERIN, NADOLOL, NADOLOL, NEOMYCIN SULFATE, NICOTINE, NICOTINE, NICOTINAMIDE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOITNE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, NICOTINE POLACRILEX, NICOITNE POLACRILEX, NICOTINE POLACRILEX GUM, NICOTINE, OXYBUTYNIN CHLORIDE, OXYBUTYNIN CHLORIDE, PANTOPRAZOLE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREGABALIN, PREGABALIN, MESALAMINE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, POLYMYXIN B SULFATE, POLYMYXIN B SULFATE, PREDNISONE, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, INFLIXIMAB, INFLIXIMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, MESALAMINE, MESALAMINE, SIMVASTATIN, CARBOXYMETHYLCELLULOSE SODIUM, CARBOXYMETHYLCELLULOSE SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, METHYLPREDNISOLONE SODIUM SUCCINATE, MORPHINE SULFATE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIMETHOPRIM, VALSARTAN, VALSARTAN, VALSARTAN, VALSARTAN, VEDOLIZUMAB, VEDOLIZUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, VITAMIN E, CREAM, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ZINC CHLORIDE, ZINC OXIDE, ZINC OXIDE OINTMENT, SKIN PROTECTANT, MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
342 | 25085888 |
JP |
80 | 1 |
Hypocalcaemia, Malaise, Asthenia, Trousseau^s sign, Hypophosphataemia, Blood parathyroid hormone increased, Renal failure, Anaemia, Metastases to bone, Malignant neoplasm progression, Renal tubular acidosis, Renal impairment, Dosage not adjusted, |
||||
ZOLEDRONIC ACID, BICALUTAMIDE, GOSERELIN, |
||||
343 | 25086254 |
90 | 1 | |
Anaemia, Blood creatinine increased, Fall, Hypotension, Rhabdomyolysis, Syncope, Emergency care, |
||||
APIXABAN, |
||||
344 | 25086297 |
81 | 1 | |
Anaemia, Gastrointestinal haemorrhage, |
||||
APIXABAN, APIXABAN, |
||||
345 | 25086307 |
67 | 1 | |
Anaemia, Gastrointestinal haemorrhage, |
||||
APIXABAN, ASPIRIN, ASPIRIN 81MG, ASPIRIN 325MG, ASPIRIN, ASPIRIN 81MG, ASPIRIN 325MG, |
||||
346 | 25086468 |
AR |
2 | |
Platelet count decreased, Pneumonia, Pulmonary mass, Anaemia, Haematocrit abnormal, Haemoglobin abnormal, Tumour marker abnormal, Toxicity to various agents, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, LEUPROLIDE, |
||||
347 | 25086572 |
RO |
34 | 2 |
Thrombocytopenia, Anaemia, Foetal exposure during pregnancy, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
348 | 25086637 |
JP |
||
Anaemia, Renal impairment, |
||||
OLAPARIB, OLAPARIB, |
||||
349 | 25089137 |
68 | 1 | |
Anaemia, Gastrointestinal haemorrhage, |
||||
APIXABAN, |
||||
350 | 25089146 |
66 | 1 | |
Anaemia, Gastrointestinal haemorrhage, Bleeding varicose vein, |
||||
APIXABAN, |
||||
351 | 25089492 |
78 | 1 | |
Anaemia, Leukopenia, Myelosuppression, Thrombocytopenia, Cirrhosis alcoholic, Oropharyngeal pain, Rhinorrhoea, |
||||
LINEZOLID, |
||||
352 | 25089557 |
59 | 1 | |
Angioedema, Anaemia, Hypertension, |
||||
LISINOPRIL, |
||||
353 | 25081225 |
PL |
23 | 2 |
Dermatitis exfoliative generalised, Petechiae, Skin exfoliation, Pleural effusion, Oral disorder, Angular cheilitis, Extravasation, Coating in mouth, Skin lesion, Respiratory failure, Pulmonary oedema, Hypoxia, Transfusion-related acute lung injury, Acute hepatic failure, Haemorrhagic diathesis, Yellow skin, Hepatosplenomegaly, Generalised oedema, Ocular icterus, Encephalopathy, Coma, Multiple organ dysfunction syndrome, Pneumonia, Rash macular, Rash erythematous, Loss of consciousness, Pyrexia, Jaundice, Rash, Dermatitis, Purpura, Coagulopathy, Lymphadenopathy, Anaemia, Liver injury, |
||||
CLARITHROMYCIN, CLARITHROMYCIN, CLARITHROMYCIN, CLARITHROMYCIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MESALAMINE, |
||||
354 | 25081372 |
IT |
77 | 2 |
Pneumonia, Asthenia, Decreased appetite, Dyspnoea exertional, Anaemia, Fatigue, Nausea, |
||||
CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, NIVOLUMAB, IPILIMUMAB, IPILIMUMAB, IPILIMUMAB, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, FOLIC ACID, AMOXICILLIN AND CLAVULANATE POTASSIUM, |
||||
355 | 25081566 |
CA |
75 | 1 |
Dyspnoea, Chest pain, Anaemia, Upper gastrointestinal haemorrhage, Transfusion, |
||||
RIVAROXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALBUTEROL SULFATE, ALBUTEROL, PREGABALIN, ROSUVASTATIN, MELATONIN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, INDAPAMIDE, |
||||
356 | 25084186 |
1 | ||
Pneumonia, Anaemia, Bacteraemia, Renal impairment, |
||||
ERYTHROPOIETIN, |
||||
357 | 25080722 |
MX |
79 | 2 |
Sepsis, Neutropenia, Thrombocytopenia, Brain neoplasm benign, Leukopenia, Fall, Humerus fracture, Immunoglobulins decreased, Light chain analysis increased, Anaemia, Intentional product use issue, |
||||
DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, LENALIDOMIDE, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DENOSUMAB, |
||||
358 | 25080797 |
DE |
82 | 2 |
Aortic valve stenosis, Myocardial infarction, Escherichia infection, Acute kidney injury, Dyspnoea, Pancreatic steatosis, Haemarthrosis, Wound dehiscence, Diverticulum intestinal, Hyperkalaemia, Hyponatraemia, Anuria, Groin pain, Tachyarrhythmia, Cardiovascular disorder, Joint dislocation, Anaemia, Femoral hernia incarcerated, Osteopenia, Investigation abnormal, Fall, Diverticulum intestinal, Abdominal discomfort, Arterial haemorrhage, Groin pain, Hernia repair, Faecaloma, Lymphatic fistula, Pulmonary hypertension, Left ventricular dysfunction, Pseudomonas infection, Decreased appetite, Gastrointestinal haemorrhage, Haematuria, Cardiac disorder, Seroma, General physical health deterioration, Oedema peripheral, Impaired healing, Hiatus hernia, Arthralgia, Gait disturbance, Escherichia infection, Peripheral swelling, Myelodysplastic syndrome, Eructation, Mitral valve incompetence, Vomiting, Tricuspid valve incompetence, Eructation, Aplastic anaemia, Hepatic cyst, Inflammatory marker increased, Joint dislocation, Dyspepsia, Aortic arteriosclerosis, Coronary artery disease, Syncope, Urinary tract infection, Tricuspid valve incompetence, Postoperative wound infection, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, DICLOFENAC, DICLOFENAC SODIUM, AMIODARONE HYDROCHLORIDE, TROSPIUM CHLORIDE, TROSPIUM CHLORIDE, TROSPIUM CHLORIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, LOSARTAN POTASSIUM, LOSARTAN, CLOPIDOGREL BISULFATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TORSEMIDE, TORSEMIDE, TORSEMIDE, TORSEMIDE, LACTULOSE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TROSPIUM CHLORIDE, TROSPIUM CHLORIDE, FENTANYL, TROSPIUM CHLORIDE, TROSPIUM CHLORIDE, TROSPIUM CHLORIDE, SIMVASTATIN, VALSARTAN, FOLIC ACID, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, EDOXABAN TOSYLATE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, TORSEMIDE, TORSEMIDE, TORSEMIDE, |
||||
359 | 25080891 |
PL |
35 | 1 |
Anaemia, Neutropenia, |
||||
CISPLATIN, ETOPOSIDE, |
||||
360 | 25080899 |
FR |
53 | 2 |
Hypercalcaemia, Acute kidney injury, Pneumocystis jirovecii pneumonia, Blood 1,25-dihydroxycholecalciferol increased, Anaemia, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
361 | 25076961 |
JP |
||
Aplasia pure red cell, Colon cancer, Large intestine polyp, Anaemia, |
||||
DAPRODUSTAT, DARBEPOETIN ALFA, |
||||
362 | 25077464 |
CN |
66 | 1 |
Myelosuppression, Platelet count decreased, Neutrophil count decreased, White blood cell count decreased, Anaemia, |
||||
VENETOCLAX, VENETOCLAX, CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, IDARUBICIN HYDROCHLORIDE, IDARUBICIN HYDROCHLORIDE, WATER, STERILE WATER, STERILE WATER FOR INJECTION, |
||||
363 | 25077777 |
JP |
1 | |
Ileal ulcer, Melaena, Anaemia, |
||||
BALOXAVIR MARBOXIL, |
||||
364 | 25077819 |
HU |
2 | |
Death, COVID-19, Hepatitis, Chronic myelomonocytic leukaemia, Cytopenia, Gastrointestinal haemorrhage, Thrombocytopenia, Anaemia, Blood lactate dehydrogenase increased, Monocytosis, Fibrosis, Hepatosplenomegaly, |
||||
GILTERITINIB, VENETOCLAX, |
||||
365 | 25077970 |
SI |
66 | 2 |
Death, Acute myeloid leukaemia recurrent, Interstitial lung disease, Pneumonitis, Thrombocytopenia, Anaemia, |
||||
GILTERITINIB, GILTERITINIB, |
||||
366 | 25078037 |
US |
20 | 2 |
Tuberculosis, Amenorrhoea, Anaemia, Blood disorder, |
||||
LEVONORGESTREL, |
||||
367 | 25078056 |
CN |
||
Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Pneumonia, Neutropenia, Sepsis, Febrile neutropenia, Neurotoxicity, Thrombocytopenia, Septic shock, Cytomegalovirus infection reactivation, Tumour lysis syndrome, Neuropathy peripheral, Hypogammaglobulinaemia, Colitis, Pulmonary embolism, Pyelonephritis, Myocarditis, Necrotising fasciitis, Progressive multifocal leukoencephalopathy, Pancytopenia, Cytomegalovirus viraemia, COVID-19, Pyrexia, Infection, Anaemia, Hypotension, Influenza, Injection site erythema, Nausea, Headache, Fatigue, Diarrhoea, Serum ferritin increased, Cytomegalovirus infection, Blood creatinine increased, |
||||
TECLISTAMAB, |
||||
368 | 25078124 |
ES |
7 | 1 |
Anaemia, Thrombocytopenia, Hepatotoxicity, Drug interaction, Drug ineffective, Drug level increased, Myelosuppression, Malignant neoplasm progression, |
||||
LINEZOLID, LINEZOLID, LINEZOLID, MIRTAZAPINE, PACLITAXEL, VINORELBINE, CARBOPLATIN, CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, TRIMETHOPRIM, LINEZOLID, LINEZOLID, LINEZOLID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, APIXABAN, ALPRAZOLAM, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CEFTRIAXONE, CEFTRIAXONE SODIUM, AMIKACIN, |
||||
369 | 25078272 |
PL |
65 | 2 |
Non-small cell lung cancer, Leukopenia, Thrombocytopenia, Anaemia, Platelet count decreased, |
||||
CARBOPLATIN, CARBOPLATIN, NIVOLUMAB, NIVOLUMAB, IPILIMUMAB, IPILIMUMAB, PACLITAXEL, PACLITAXEL, |
||||
370 | 25078504 |
BR |
2 | |
Heavy menstrual bleeding, Anaemia, Eye pain, Mydriasis, Multiple sclerosis relapse, Pain, Iron deficiency anaemia, Adenomyosis, Vitamin B12 deficiency, Amnesia, COVID-19, Thrombosis, Bladder injury, Cognitive disorder, Pernicious anaemia, Gastritis, |
||||
NATALIZUMAB, NATALIZUMAB, NATALIZUMAB, NATALIZUMAB, NATALIZUMAB, NATALIZUMAB, NATALIZUMAB, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, PREGABALIN, |
||||
371 | 25078733 |
RO |
51 | 1 |
Acute respiratory failure, Thrombocytopenia, Leukopenia, Neutropenia, Secondary immunodeficiency, Pneumonia bacterial, Anaemia, Thrombophlebitis, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DARATUMUMAB, CARFILZOMIB, |
||||
372 | 25078846 |
US |
25 | 2 |
Device allergy, Uterine leiomyoma, Reproductive complication associated with device, Loss of consciousness, Seizure, Blindness, Device breakage, Foreign body in urogenital tract, Complication of device removal, Embedded device, Abnormal uterine bleeding, Procedural haemorrhage, Pituitary tumour benign, Headache, Weight decreased, Neurological symptom, Galactorrhoea, Hormone level abnormal, Ovulation disorder, Post-traumatic stress disorder, Depression, Anxiety, Fatigue, Dizziness, Anaemia, Menstruation irregular, Vaginal infection, Dyspareunia, Pain, Abdominal pain, |
||||
COPPER, |
||||
373 | 25079309 |
US |
62 | |
Cataract, Diabetes mellitus, Restrictive pulmonary disease, Anaemia, Obstructive airways disorder, |
||||
ROSUVASTATIN, SEMAGLUTIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, FUROSEMIDE, LOSARTAN, MONTELUKAST SODIUM, RIVAROXABAN, ROSUVASTATIN, |
||||
374 | 25079477 |
US |
78 | 1 |
Anaemia, Illness, Dementia, |
||||
VOXELOTOR, |
||||
375 | 25079577 |
RO |
33 | |
HIV-associated neurocognitive disorder, Weight decreased, Ill-defined disorder, Paresis, Malabsorption, HIV infection CDC category C, Drug resistance, Portal hypertension, Anaemia, Interstitial lung disease, Oral candidiasis, |
||||
RALTEGRAVIR, EFAVIRENZ, LAMIVUDINE, LAMIVUDINE ORAL, ATAZANAVIR SULFATE, ATAZANAVIR, ATAZANAVIR SULFATE, ATAZANAVIR, LAMIVUDINE AND ZIDOVUDINE, NELFINAVIR MESYLATE, LOPINAVIR AND RITONAVIR, |
||||
376 | 25079599 |
US |
1 | |
Bone pain, Fatigue, Pain in extremity, Vomiting, Muscular weakness, Product dose omission issue, Anaemia, Diarrhoea, |
||||
FEDRATINIB HYDROCHLORIDE, RUXOLITINIB, ALLOPURINOL, LORATADINE, LORATADINE ORAL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
377 | 25079621 |
US |
||
Acute myeloid leukaemia recurrent, Circulatory collapse, Atrial fibrillation, Electrocardiogram QT prolonged, Drug interaction, Electrocardiogram QT prolonged, Sepsis, Acute respiratory failure, Malignant pleural effusion, Anaemia, Acute kidney injury, Dehydration, Diarrhoea, |
||||
IVOSIDENIB, ISAVUCONAZONIUM SULFATE, ACYCLOVIR, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE, TAMSULOSIN HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, |
||||
378 | 25079659 |
US |
79 | 2 |
Off label use, Deep vein thrombosis, Breast mass, Palmar-plantar erythrodysaesthesia syndrome, Tumour pain, Anaemia, Ascites, Constipation, Hypertension, Iron deficiency, Vitamin B12 deficiency, Vitamin D deficiency, Haematocrit decreased, Haemoglobin decreased, Neuroendocrine carcinoma, Abdominal pain, Abnormal loss of weight, Oedema peripheral, Pelvic pain, Small intestinal obstruction, Colon cancer, Neuropathy peripheral, Leukopenia, Metastases to liver, Vomiting, Blood creatinine decreased, Platelet count increased, |
||||
BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, CAPECITABINE, CAPECITABINE, APIXABAN, AMLODIPINE, MECLIZINE HCL 12.5 MG, MECLIZINE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, SIMVASTATIN, LATANOPROST, OCTREOTIDE ACETATE, OCTREOTIDE, TRIFLURIDINE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
379 | 25079661 |
US |
68 | 1 |
Haemothorax, Anaemia, |
||||
HEPARIN SODIUM, |
||||
380 | 25079849 |
US |
64 | 1 |
Benign prostatic hyperplasia, Catheter site thrombosis, Catheter site injury, Syncope, Anaemia, Intentional dose omission, |
||||
ICOSAPENT ETHYL, ICOSAPENT ETHYL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
381 | 25079970 |
JP |
||
Endometrial cancer stage II, Vaginal haemorrhage, Anaemia, Polycystic ovaries, |
||||
TESTOSTERONE, TESTOSTERONE,, |
||||
382 | 25080056 |
US |
68 | 2 |
Endometrial cancer recurrent, Anaemia, Cortisol decreased, Blood test abnormal, Hospitalisation, Product use issue, Illness, |
||||
PEMBROLIZUMAB, |
||||
383 | 25080204 |
US |
2 | |
Anaemia, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, |
||||
384 | 25072390 |
US |
||
Neuromyelitis optica spectrum disorder, Poor venous access, Migraine, Anaemia, |
||||
SATRALIZUMAB, |
||||
385 | 25072492 |
RO |
||
Haematotoxicity, Anaemia, Thrombocytopenia, Leukocytosis, |
||||
OLAPARIB, |
||||
386 | 25072837 |
CA |
65 | 2 |
Angina pectoris, Anaemia, Arthralgia, Arthritis, Balance disorder, Body temperature decreased, Bone pain, Bronchitis, Contusion, Cough, Deafness transitory, Dizziness, Dyspepsia, Ear discomfort, Fatigue, Feeling abnormal, Feeling hot, Frustration tolerance decreased, Gait disturbance, Headache, Hyperhidrosis, Illness, Influenza, Irritability, Joint swelling, Meniere^s disease, Oliguria, Oropharyngeal pain, Pain, Pain in extremity, Paraesthesia, Paraesthesia oral, Peripheral swelling, Pneumonia, Respiratory fume inhalation disorder, Sense of oppression, Sensitivity to weather change, Sinusitis, Sputum discoloured, Tinnitus, Tumour compression, Vertigo, Viral infection, Visual impairment, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE FUROATE, BUDESONIDE, FUROSEMIDE, DIMENHYDRINATE, ATORVASTATIN CALCIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
387 | 25073370 |
JP |
1 | |
Hypomagnesaemia, Neutropenia, Renal disorder, Arthralgia, Aspartate aminotransferase increased, Alanine aminotransferase increased, Anaemia, Condition aggravated, Fatigue, Tremor, Dizziness, |
||||
CARBOPLATIN, PACLITAXEL, |
||||
388 | 25073397 |
FR |
14 | 2 |
Hypertension, Fatigue, Anaemia, Thrombocytopenia, Drug ineffective, Hypothyroidism, Off label use, Diarrhoea, |
||||
AXITINIB, THIOTEPA, ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, |
||||
389 | 25073867 |
SE |
77 | 1 |
Rectal haemorrhage, Anaemia, Angiodysplasia, Melaena, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
390 | 25073942 |
CA |
||
Haemoglobin decreased, Dyspnoea, Chest pain, Anaemia, Feeling abnormal, Product prescribing error, Off label use, |
||||
MOMELOTINIB, MOMELOTINIB, |
||||
391 | 25074200 |
FR |
74 | 1 |
Lactic acidosis, Acute kidney injury, Anaemia, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SACUBITRIL AND VALSARTAN, DAPAGLIFLOZIN, INSULIN GLARGINE, BISOPROLOL FUMARATE, |
||||
392 | 25074300 |
CN |
69 | |
Neutropenic sepsis, Platelet count decreased, Anaemia, Pneumonia, Respiratory failure, Cardiac failure acute, Off label use, Prescribed underdose, |
||||
SELINEXOR, SELINEXOR, SELINEXOR, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, |
||||
393 | 25074315 |
FR |
2 | 2 |
Diarrhoea, Anaemia, Incorrect dose administered, Overdose, |
||||
AZITHROMYCIN DIHYDRATE, |
||||
394 | 25074317 |
FR |
64 | 2 |
Neutropenia, Myelodysplastic syndrome, Anaemia, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, |
||||
395 | 25074853 |
PL |
74 | 1 |
Anaemia, Thrombocytopenia, |
||||
CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
396 | 25075030 |
EG |
2 | |
Multiple sclerosis relapse, Multiple sclerosis relapse, Multiple sclerosis relapse, Multiple sclerosis relapse, Weight increased, Gait disturbance, Fatigue, Anaemia, Memory impairment, Dry mouth, |
||||
FINGOLIMOD HCL, SIPONIMOD, |
||||
397 | 25075243 |
CN |
||
Neutropenia, Leukopenia, Hypokalaemia, Cervix carcinoma, Febrile neutropenia, Thrombocytopenia, Injection site pain, Gastrointestinal disorder, Transaminases abnormal, Anaemia, Bone pain, Arthralgia, |
||||
FILGRASTIM, PEGFILGRASTIM, CISPLATIN, CARBOPLATIN, |
||||
398 | 25075265 |
US |
1 | |
Anaemia, Anaemia, |
||||
UPADACITINIB, UPADACITINIB, |
||||
399 | 25075425 |
PG |
1 | |
Anaemia, Blast cell crisis, White blood cell count increased, Therapy non-responder, |
||||
NILOTINIB, |
||||
400 | 25075603 |
CN |
29 | 2 |
Inappropriate schedule of product administration, Acute myeloid leukaemia recurrent, Agranulocytosis, Platelet count decreased, Anaemia, Febrile infection, Loss of consciousness, Respiratory rate increased, Oxygen saturation decreased, Heart rate increased, Blood pressure diastolic increased, |
||||
CYTARABINE, IDARUBICIN HYDROCHLORIDE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28